Navigation Links
Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Date:6/2/2008

NEW HAVEN, Conn., June 2 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that interim data from the pivotal Phase II trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in elderly patients with de novo poor-risk acute myelogenous leukemia (AML) had been presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO(R)) in Chicago, Illinois.

At ASCO(R), data were presented in 85 evaluable patients. The median age of these patients was 73 years (range of 60-87 years). Ninety-five percent of patients had two or more risk factors associated with a poor prognosis in elderly AML and 74% had three or more risk factors. The most common risk factors were age greater than or equal to 70 (78% of patients), and cardiac and pulmonary dysfunction (73% and 76% of patients respectively). In addition, 47% of patients had unfavorable cytogenetics.

The overall complete response rate was 35% (22 CR and 8 CRp). 90% of responses occurred after first induction treatment. While follow-up is still ongoing, the median (range) of overall survival for responders was 6.3 months (1.7-16.4 months) and for all patients was 3.2 months (0.1-16.4 months).

The induction death rate within 30 days of first induction treatment was 14%. The majority of first induction deaths were either due to progression of disease or infection. Myelosuppression was the primary toxicity, with pneumonia, infection and sepsis and non-infectious pulmonary disorders (hypoxia and dyspnea) being the most common severe adverse events (greater than or equal to grade 3).

Dr. Gary Schiller, Professor of Medicine at the David Geffen School of Medicine at UCLA and a lead investigator on the study, said "The
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
2. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
3. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
4. Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
5. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
6. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
7. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
8. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
9. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
10. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
11. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014   LabStyle Innovations Corp ... today announced the appointment of Professor Richard ... its Board of Directors. Prof. Stone ... experience to LabStyle as an entrepreneur, venture capitalist ... corporate governance expert. He currently serves on the ...
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
(Date:7/11/2014)... 2014 Superior Labs announce the launch ... supplements to aid in maintaining optimal digestive health by ... metabolism of fat. Formulated and manufactured in the U.S ... is available in all-natural, vegetarian capsules, with each capsule ... Health Benefits of Artichoke Leaf Extract , Superior Labs ...
(Date:7/11/2014)... TN (PRWEB) July 11, 2014 This morning(July ... Fox 13--Good Morning Memphis to discuss the illegal immigration crisis ... border town of McAllen, Texas. , Dr. Flinn told Good ... it is absolutely wide open… The problem is that they ... influx. Thousands of people per day are coming into the ...
(Date:7/11/2014)... July 11, 2014 Yisrayl Hawkins, Pastor and ... a letter pleading to let the children from other nations, ... allowed to come. Yisrayl says President Barack Obama is fighting ... the United States, and he wants to help him. ... from Guatemala, Honduras and El Salvador being treated as if ...
(Date:7/11/2014)... 2014 Shu Cosmetic Surgery announces ... each qualifying patient undergoing a laser vaginal ... laser vaginal rejuvenation, an advanced type of vaginal ... procedure decreases the internal and external diameters of ... strength, and control, resulting in enhanced sexual gratification ...
(Date:7/11/2014)... TX (PRWEB) July 11, 2014 Based ... urgent care to residents of Brazoria County and surrounding ... that the clinic is now accessible from Northbound Highway ... as a center where patients can get low-cost urgent ... are far from rare, finding places that can match ...
Breaking Medicine News(10 mins):Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Senate Candidate, George Flinn on Fox13 NEWS About the Border Crisis 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 3Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2
... , , KIBBUTZ SHAMIR, ... SHMR ) (" Shamir ") expects to issue its second quarter ... a conference call to discuss the results at 11:00 A.M. EDT that ... broadcast live as a listen-only webcast. To listen live, please go to ...
... , , BETHESDA, Md., Aug. 6 ... developing novel, proprietary antibodies for the treatment of cancer, inflammation ... second quarter and six months ended June 30, 2009. , ... Micromet achieved a number of significant milestones illustrating its continued ...
... revised higher based on solid year-to-date performance and, positive ... Aug. 6 /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" or the "Company") ... the three- and six-month periods ended June 30, 2009. Financial references are ... Q2 2009 Highlights, ------------------, - ...
... , , WILMINGTON, Mass., Aug. 6 DUSA Pharmaceuticals, ... highlights and second quarter financial results press release will be issued on Tuesday, August ... , , Tuesday, August 11 - 8:30 a.m. E.T. , ... 800.647.4314 , Password - DUSA , , ...
... ... two additional contracts to the RTP, NC-based life sciences company Entegrion, ... safety and availability of blood-derived products for treating combat injuries. ... essential in responding to traumatic injury, especially on the battlefield. ...
... , ... plans provided by GetOnlineQuotes.com offer the best value in the current marketplace. , ... Miami, FL (PRWEB) August ... by law, the AARP Medicare Supplement ( http://www.getonlinequotes.com/aarp-medicare-insurance.html ) rates offered by ...
Cached Medicine News:Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 2Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 2Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 3Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 4Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 5Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 6Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 7Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 8Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 9Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 10Health News:Micromet, Inc. Reports Second Quarter 2009 Financial Results 11Health News:SXC Health solutions announces record second quarter financial results 2Health News:SXC Health solutions announces record second quarter financial results 3Health News:SXC Health solutions announces record second quarter financial results 4Health News:SXC Health solutions announces record second quarter financial results 5Health News:SXC Health solutions announces record second quarter financial results 6Health News:SXC Health solutions announces record second quarter financial results 7Health News:SXC Health solutions announces record second quarter financial results 8Health News:SXC Health solutions announces record second quarter financial results 9Health News:SXC Health solutions announces record second quarter financial results 10Health News:SXC Health solutions announces record second quarter financial results 11Health News:SXC Health solutions announces record second quarter financial results 12Health News:SXC Health solutions announces record second quarter financial results 13Health News:SXC Health solutions announces record second quarter financial results 14Health News:SXC Health solutions announces record second quarter financial results 15Health News:SXC Health solutions announces record second quarter financial results 16Health News:SXC Health solutions announces record second quarter financial results 17Health News:SXC Health solutions announces record second quarter financial results 18Health News:SXC Health solutions announces record second quarter financial results 19Health News:U.S. Navy Awards Entegrion Contracts for $4 Million for the Development of Critical Blood Products 2Health News:U.S. Navy Awards Entegrion Contracts for $4 Million for the Development of Critical Blood Products 3Health News:GetOnlineQuotes.com to Offer AARP/United Healthcare Medicare Supplement Insurance to Florida Residents 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: